Oaktree Strategic Income Corp Stock News

Oaktree Specialty Lending Inc (NASDAQ:OCSL) was trading 0.10% lower from the previous closing price. Ruben Richard filed a Form 4 with the SEC on Wednesday, August 19. The insider...

Tras la incorporación de González-Bueno como presidente no ejecutivo, el fondo acaba de fichar al director corporativo y al responsable de desarrollo, que reportarán directamente a Francisco Pérez

OCSL earnings call for the period ending June 30, 2020.

OCSI earnings call for the period ending June 30, 2020.

Para a Oaktree, liderada por Howard Marks, a rápida recuperação dos mercados não condiz com a atual situação econômica. Clique para ler mais.

Oaktree Strategic Income (OCSI) delivered earnings and revenue surprises of -15.38% and -17.75%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the sto

Shares of Oaktree Strategic Income (NASDAQ:OCSI) were unchanged after the company reported Q3 results.Quarterly Results Earnings per share were down 45.00% year over year to $0.11, which missed the es

Oaktree Strategic Income Corporation (NASDAQ: OCSI) (“Oaktree Strategic Income” or the “Company”), a specialty finance company, today announced its financial

LOS ANGELES, CA, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Oaktree Strategic Income Corporation (NASDAQ: OCSI) (“Oaktree Strategic Income” or the “Company”), a specialty finance company, today announc

[SAN FRANCISCO] Hims Inc, a telemedicine company that sells wellness and healthcare products, is in talks to go public through a merger with blank-check company Oaktree Acquisition Corp, according to

Hims Inc., a telemedicine company that sells wellness and health-care products, is in talks to go public through a merger with blank-check company Oaktree Acquisition Corp., according to people with k

Oaktree Capital Group Co-Founder Howard Marks says the Federal Reserve’s intervention at the peak of the pandemic was necessary to keep companies afloat and avoid a potential economic shutdown, even

Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the

The US economy is reporting some of the worst fundamentals in our nation's history. GDP fell 32.9% in Q2 and small businesses are closing at a steady and high rate.